Pharmafile Logo
Pharmafocus logo
Advanced Search

Astellas appoints VP of Scientific and Medical Affairs

November 9, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Jeffrey Bloss

Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …

Appointment
speakerwilliamsmarth

Leadership changes at Teva

November 8, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva

Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …

Appointment
janssen image

Janssen and GSK in hep C tie-ups

November 8, 2012
Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C

Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …

News
bad pharma image

Goldacre is right – greater honesty is needed

November 7, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, Les Rose

One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …

Feature

‘Patchy’ NHS Constitution needs improving

November 7, 2012
Sales and Marketing DoH, Future Forum, NHS, commissioning

The NHS Future Forum has criticised the NHS Constitution for not being up to scratch and suggested ‘essential steps’ to …

News
screen_shot_2012-11-07_at_10

Sanofi’s chief executive new president elect of EFPIA

November 7, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Viehbacher, Sanofi

European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …

Appointment
Takeda HQ image

Takeda to buy Envoy Therapeutics

November 7, 2012
Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda

Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …

News
Pfizer Sandwich image

Pfizer backs new biotech firm

November 6, 2012
Research and Development, Sales and Marketing Pfizer, Sandwich, Ziarco

Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …

News

Pharma manufacturing news in brief

November 6, 2012
Manufacturing and Production Cytovance, DSM, Insipiration, Neolpharma, Paranta, Patheon

A round up of recent pharma manufacturing news, including an Ipsen/Inspiration facility up for sale, new contracts for Patheon, Cytovance …

News
goldrick

First Northern Ireland director for ABPI announced

November 6, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Colette Goldrick, Ireland

The ABPI has confirmed the appointment of Colette Goldrick as its new Northern Ireland director and as a member of …

Appointment
Astrazeneca image

MRC gives £7 million to new projects

November 6, 2012
Sales and Marketing AstraZeneca, MRC, academics

The Medical Research Council (MRC) has handed out £7 million in funding for 15 research projects which will use a …

News
lilly image

New plant positions Lilly for changing insulin market

November 6, 2012
Manufacturing and Production Boehringer, insulin, lilly

Eli Lilly has unveiled plans for a $140 million expansion of its insulin plant in Indianapolis as it starts to …

News
Xarelto image

Further US approval for Xarelto

November 5, 2012
Sales and Marketing Eliquis, FDA, Pradaxa, Xarelto

US regulators have given the go-ahead to expand the indications for which Janssen Pharmaceuticals and Bayer HealthCare’s oral blood thinner …

News

Bayer to acquire Schiff Nutrition

November 4, 2012
Sales and Marketing Bayer, mergers and acquisitions

Bayer HealthCare is to buy US-based vitamins and nutritional supplements firm Schiff Nutrition International for $1.2 billion.The deal is part …

News

Pfizer stumbles in third quarter

November 2, 2012
Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3

Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …

News

Sanofi criticised for multiple sclerosis manoeuvres

November 2, 2012
Sales and Marketing Cancer, Lemtrada, MS, Sanofi

Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …

News
screen_shot_2012-11-02_at_09

COPA-DATA appoints new UK managing director

November 2, 2012
Manufacturing and Production, Research and Development, Sales and Marketing COPA-DATA, Martyn Williams

Ergonomic process solutions firm COPA-DATA has appointed Martyn Williams as UK managing director with immediate effect. A qualified electronic engineer, …

Appointment
Novartis image

Novartis says Canada and Switzerland lift vaccines ban

November 2, 2012
Manufacturing and Production Canada, Novartis, Switzerland, vaccines

A temporary suspension on the distribution of flu vaccines made by Novartis has been lifted in Canada and Switzerland. The …

News
yervoy image

NICE hails ‘breakthrough’ skin cancer treatments

November 2, 2012
Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf

Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …

News
Ameridose iamge

Meningitis probe extends to NECC sister company

November 1, 2012
Manufacturing and Production NECC, ameridose, meningitis

A second compounding pharmacy has been drawn into the investigation into the meningitis outbreak that has killed 29 people in …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026